C h a p t e r 1 6
Disorders of the Immune Response
373
A.
Why did the provider do an HIV test after the
man was diagnosed with PCP?
B.
Is there a way to prevent PCP?
C.
What classification does this man fall into based
on his CD4
+
count and symptomatology, and why?
R E F E R E N C E S
1. Abbas AK, Lichtman AH, Pillai S.
Cellular and Molecular
Immunology
. 7th ed. Philadelphia, PA: Elsevier Saunders;
2012:319–344, 365–388, 407–424, 445–470.
2. Kumar V, Abbas AK, Fautso N, et al.
Robbins and Cotran
Pathologic Basis of Disease
. 8th ed. Philadelphia, PA: Saunders
Elsevier; 2010:183–249.
3. Warren JS, Strayer DS. Immunopathology. In: Rubin R, Strayer
DS, eds.
Rubin’s Pathology: Clinicopathologic Foundations
of Medicine
. 6th ed. Philadelphia, PA: Lippincott Williams &
Wilkins; 2012:115–156.
4. Kay AB. Allergy and allergic disease (parts 1 and 2).
N Engl J
Med.
2001;344:(1,2)30–37, 109–113.
5. Galli SJ. New concepts about the mast cell.
N Engl J Med.
1993;328:257–265.
6. Arnold JJ, Williams PAM. Anaphylaxsis: recognition and
management.
Am Fam Physician.
2011;84(10):1111–1118.
7. Lieberman P. Anaphylaxis.
Med Clin North Am.
2006;90:77–95.
8. Lieberman P, Kemp SF, Oppenheimer J, et al.; Chief Editors
for the Joint Task Force on Practice Parameters, Joint Counsel
of Allergy, Asthma and Immunology. The diagnosis and
management of anaphylaxis: an updated practice parameter.
J Allergy Clin Immunol.
2005;115(3 suppl):S483–S523.
9. Mucci T, Govindaraj S, Tversky J. Allergic rhinitis.
Mt Sinai J
Med.
2011;78(5):634–644.
10. Steinsvaag SK. Allergic rhinitis: an updated overview.
Curr
Allergy Asthma Rep.
2012;12:99–103.
11. Sicherer SH, Sampson HA. Food allergy.
J Allergy Clin Immunol.
2010;125:S116–S125.
12. Masilamani M, Commins S, Shreffler W. Determinants of food
allergy.
Immunol Allergy Clin North Am.
2012;33:11–33.
13. Sampson HA. Peanut allergy.
N Engl J Med.
2002;346:1294–1299.
14. Berke RC, Singh A, Guralnice M. Atopic dermatitis: an overview.
Am Fam Physician.
2012;86:35–42.
15. Mark BJ, Slavin RG. Allergic contact dermatitis.
Med Clin North
Am.
2006;90:169–185.
16. Ohshimo S, Bonella F, Guzman J, et al. Hypersensitivity
pneumonitis.
Immunol Allergy Clin North Am.
2012;32:537–556.
17. Gilliam AC. Update on graft versus host disease.
J Invest
Dermatol.
2004;123:251–257.
18. Choi SW, Levine JE, Ferrara JLM. Pathogenesis and management
of graft-versus-host disease.
Immunol Allergy Clin North Am.
2010;30:75–101.
19. Crawford JM. The liver and biliary tract. In: Kumar V, Abbas AK,
Fausto N, eds.
Robbins and Cotran Pathologic Basis of Disease
.
7th ed. Philadelphia, PA: Elsevier Saunders; 2005:919–920.
20. Yin Y, Yili L, Maniuzza RA. Structural basis for self-recognition by
autoimmune T-cell receptors.
Immunol Rev.
2012;250(1):32–48.
21. Davidson A, Diamond B. Autoimmune disease.
N Engl J Med.
2001;345:340–350.
22. Rioux JD, Abbas AK. Paths to understanding the genetic basis of
autoimmune disease.
Nature.
2005;435:584–589.
23. Goodnow CC, Sprent J, de St Groth BF, et al. Cellular and
genetic mechanisms of self tolerance and autoimmunity.
Nature.
2005;435:590–597.
24. Navratil JS, Sabatine JM, Ahearn JM. Apoptosis and immune
responses to self.
Rheum Dis Clin North Am.
2004;30:193–212.
25. Jiang H, Chess L. Regulation of immune responses by T cells.
N
Engl J Med.
2006;354:166–176.
26. Kronberg M, Rudensky A. Regulation of immunity by self-
reactive T cells.
Nature.
2005;435:598–604.
27. Zandman-Goddard G, Peeva E, Shoenfeld Y. Gender and
autoimmunity.
Autoimmun Rev.
2007;6:366–372.
28. Cutolo M, Sulli A, Seriolo S, et al. Estrogens, the immune response
and autoimmunity.
Clin Exp Rheumatol.
1995;13:217–226.
29. Cusick MF, Libbey JE, Fujinami RS. Molecular mimicry as a
mechanism of autoimmune disease.
Clin Rev Allergy Immunol.
2012;42:102–111.
30. Anders H-J, Zecher D, Pawar RD, et al. Molecular mechanisms
of autoimmunity triggered by microbial infection.
Arthritis Res
Ther.
2005;7:215–224.
31. Llewelyn M, Cohen J. Superantigen antagonist peptides.
Crit
Care.
2001;5:53–55.
32. Verbsky JW, Grossman WJ. Cellular and genetic basis of primary
immune deficiencies.
Pediatr Clin North Am.
2006;53:649–684.
33. Bonilla FA, Geha RS. Update on primary immunodeficiency
diseases.
J Allergy Clin Immunol.
2006;117(2 suppl):S435–S441.
34. Parvaneh N, Casanova J-L, Notarangelo LD. Primary
immunodeficiencies: a rapidly evolving story.
J Allergy Clin
Immunol.
2013;131:314–323.
35. Buckley R. Evaluation of suspected immunodeficiency. In:
Kliegman RM, Stanton BF, St Gemelli JW, et al.
Nelson Textbook
of Pediatrics
. 19th ed. Piladelphia, PA: Elsevier Saunders,
2011:714–722.e1.
36. The Jeffrey Modell Foundation Medical Advisory Board.
Ten
Warning Signs of Primary Immunodeficiency
. 2009. Available at:
tent=warningsigns. Accessed August 26, 2013.
37. Sorensen RU, Moore C. Antibody deficiency syndromes.
Pediatr
Clin North Am.
2000;47:1225–1252.
38. Rose ME, Lang DM. Evaluating and managing
hypogammaglobulinemia.
Cleve Clin J Med.
2006;73:133–144.
39. Elder ME. T-cell immunodeficiencies.
Pediatr Clin North Am.
2000;47:1253–1274.
40. Buckley RH. Molecular defects in human severe combined
immunodeficiency and approaches to immune reconstitution.
Annu Rev Immunol.
2004;22:625–655.
41. Rudd CE. Disabled receptor signaling and new primary
immunodeficiency disorders.
N Engl J Med.
2006;354:1874–1877.
42. Buckley RH. The long quest for neonatal screening for
severe combined immunodeficiency.
J Allergy Clin Immunol.
2012;129(3):597–604.
43. Ochs HD, Thrasher AJ. The Wiskott-Aldrich syndrome.
J Allergy
Clin Immunol.
2006;117:725–738.
44. UNAIDS.
2012 UNAIDS Report on the Global AIDS Epidemic,
November 2012
. Available at:
publications/2012/name,76121,en.asp. Accessed August 26, 2013.
45. Karim SSA, Karim QA, Gouws E, et al. Global epidemiology of
HIV-AIDS.
Infect Dis Clin North Am.
2007;21:1–17.
46. Zetola NM, Pilcher CD. Diagnosis and management of acute
HIV infection.
Infect Dis Clin North Am.
2007;21:19–48.
47. UNAIDS.
2008 Report on Global AIDS Epidemic, August
2008
. Available at:
HIVData/GlobalReport/2008/2008_Global_report.asp. Accessed
August 26, 2013.
48. Gershon RRM, Vlahov D, Nelson KE. The risk of transmission
of HIV-1 through non-percutaneous, non-sexual modes: a review.
AIDS.
1990;4:645–650.
49. Public Health Agency of Canada.
Summary: Estimation
of HIV prevalence and incidence in Canada, 2011
. 2012.
Available at:
/
survreport/2011/dec/index-eng.php. Accessed August 26, 2013.
50. Centers for Disease Control and Prevention. Estimated HIV
incidence in the United States, 2007–2010.
HIV Surveillance
Supplemental Report.
December 2012;17(4). Available
at:
reports/#supplemental. Accessed August 26, 2013.
